| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | HEALTH CATALYST INC | Oct 27, 2025 | |
| Buy | HOLISTIC CAT GENESINE BLUE C | Jan 12, 2025 |
This page tracks congressional stock trading activity in Health Catalyst, Inc. (HCAT) in the Healthcare sector. Disclosed Capitol has indexed 2 disclosed congressional trades involving HCAT. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of January 2026 — Disclosed Capitol has tracked 2 disclosed congressional trades in Health Catalyst, Inc. (HCAT) — 1:1 buy-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Oct 27, 2025 | Michael McCaul | R | Sale | $15,001 - $50,000 |
| Jan 12, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 2 disclosed congressional trades in Health Catalyst, Inc. (HCAT), members of Congress have reported 1 buy and 1 sell. The average 30-day alpha vs. the S&P 500 is -17.08%.
As of September 2026, corporate insiders at Health Catalyst, Inc. have filed 11 SEC Form 4 transactions in HCAT over the past 12 months — including 1 open-market buy worth $105K.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-09-14 | Kohl Simeon — Chief Executive Officer | Award | — |
| 2026-09-14 | Kohl Simeon — Chief Executive Officer | Purchase | $105K |
| 2026-09-10 | Albert Benjamin — CEO | Tax Withholding | $59K |
| 2026-09-01 | Larson-Green Julie — Director | Award | — |
| 2026-09-01 | Alger Jason — Chief Financial Officer | Tax Withholding | $31K |
| 2026-09-01 | Albert Benjamin — CEO | Tax Withholding | $547 |
| 2026-09-01 | Landry Benjamin — General Counsel | Tax Withholding | $22K |
| 2026-07-16 | Hoggard Green Jill — Director | Award | — |
| 2026-07-16 | Larson-Green Julie — Director | Award | — |
| 2026-07-16 | Nelson Steven H — Director | Award | — |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
For fiscal year 2025, Health Catalyst, Inc. reported revenue of $311.1M and net income of -$178.0M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $70.5M, net income -$40.5M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.